Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Chimeric-anti-interleukin-6 monoclonal antibody

EU orphan designation number: EU/3/03/148
Active ingredient: Chimeric-anti-interleukin-6 monoclonal antibody
Indication: Treatment of renal cell carcinoma
Sponsor: Janssen Biologics B.V.
Einsteinweg 101, 2333 CB Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/07/2003 Orphan designation EMEA/OD/002/03 (2003)2217 of 30/06/2003
24/08/2011 Change of name and/or address of sponsor EMEA/OD/002/03
30/09/2011 Removal of orphan designation from Community Register